Technical Analysis for REVB - Revelation Biosciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Gapped Up | Strength | -3.36% | |
Upper Bollinger Band Touch | Strength | -2.13% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.95% | |
Pocket Pivot | Bullish Swing Setup | -2.95% | |
Inside Day | Range Contraction | -2.95% | |
Wide Bands | Range Expansion | -2.95% | |
Up 3 Days in a Row | Strength | -2.95% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.13% | |
Crossed Above 20 DMA | Bullish | -2.13% | |
Pocket Pivot | Bullish Swing Setup | -2.13% |
Alert | Time |
---|---|
Possible NR7 | 7 minutes ago |
Fell Below Previous Day's Low | about 1 hour ago |
Down 1% | about 1 hour ago |
10 DMA Resistance | about 2 hours ago |
60 Minute Opening Range Breakout | about 3 hours ago |
Get a Trading Assistant
- Earnings date: 05/20/2024
Revelation Biosciences, Inc. Description
Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. In addition to Revelation’s therapeutic pipeline, Revelation is also developing REVDx-501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Disease Immunology Infection Vaccination Respiratory Diseases Allergology Nasal Administration Rhinitis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 39.0 |
52 Week Low | 1.7801 |
Average Volume | 120,145 |
200-Day Moving Average | 13.43 |
50-Day Moving Average | 2.55 |
20-Day Moving Average | 2.17 |
10-Day Moving Average | 2.24 |
Average True Range | 0.23 |
RSI (14) | 44.75 |
ADX | 11.11 |
+DI | 23.73 |
-DI | 18.07 |
Chandelier Exit (Long, 3 ATRs) | 1.95 |
Chandelier Exit (Short, 3 ATRs) | 2.48 |
Upper Bollinger Bands | 2.46 |
Lower Bollinger Band | 1.88 |
Percent B (%b) | 0.61 |
BandWidth | 26.69 |
MACD Line | -0.10 |
MACD Signal Line | -0.17 |
MACD Histogram | 0.0698 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.47 | ||||
Resistance 3 (R3) | 2.49 | 2.43 | 2.43 | ||
Resistance 2 (R2) | 2.43 | 2.37 | 2.42 | 2.42 | |
Resistance 1 (R1) | 2.33 | 2.33 | 2.30 | 2.31 | 2.40 |
Pivot Point | 2.27 | 2.27 | 2.26 | 2.26 | 2.27 |
Support 1 (S1) | 2.17 | 2.21 | 2.14 | 2.15 | 2.06 |
Support 2 (S2) | 2.11 | 2.17 | 2.10 | 2.04 | |
Support 3 (S3) | 2.01 | 2.11 | 2.03 | ||
Support 4 (S4) | 1.99 |